CClinicalTrials.gg
CompletedNCT06956963Updated Jun 8, 2026Results posted

Aerobic Exercise: A Potential Rescue From the Negative Ramifications of Poor Sleep

An interventional study of Partial Sleep Deprivation in Cardiovascular Health and Sleep, sponsored by Florida State University. Completed at 1 site in United States. Open to participants aged 18 Years to 39 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-08.

Sponsored by Florida State University · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
18 Years to 39 Years
Sex
All
01

Study summary

The goal of this interventional study is to differentiate the effects of an acute partial sleep deprivation intervention on markers of cardiovascular health, cardio-autonomic function, physical and cognitive performance, as well as overall wellbeing in active vs sedentary individuals. The main aims of the project are:

  • To differentiate the effects of partial sleep deprivation on central hemodynamics (i.e., central blood pressure and arterial stiffness) in active vs sedentary individuals.
  • To differentiate the effects of partial sleep deprivation on physical (i.e., handgrip strength and reactive strength index) and cognitive performance (i.e., reaction time and impulse control) in active vs sedentary individuals.
  • To differentiate the effects of partial sleep deprivation on overall wellbeing (i.e., cardio-autonomic function, inflammation levels, and psychological mood states) in active vs sedentary individuals.

Participants will be divided into two groups based on aerobic activity level - active or sedentary - and assessed for markers of cardiovascular health, cardio-autonomic function, physical and cognitive performance, as well as overall wellbeing before and after three days of normal sleep and three days of partially deprived sleep (i.e., 30% reduction in total time in bed).

02

Conditions studied

  • Cardiovascular Health
  • Sleep
03

In context

Lead sponsor

Florida State University is the lead sponsor of 241 studies on the registry; 46 are open to participants now.

Of its 15 completed or terminated interventional studies of FDA-regulated products, 9 (60%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 39 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Chronically active (≥150 minutes of moderate- and/or ≥75 minutes of vigorous-intensity aerobic exercise per week for the last 3 months) OR
  • Sedentary (≤60 minutes of aerobic exercise per week for the last 3 months)

Exclusion criteria

Exclusion Criteria:

  • Chronic, uncontrolled disease (cardiovascular, metabolic)
  • Poor sleep (regularly achieving \<7 hours of sleep per night)
  • Musculoskeletal injury in the last 6 months
  • Obese (grade II or higher)
  • Pregnant
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
24 participants (actual)

Study arms

  • No intervention
    Normal Sleep
  • Experimental
    Acute Partial Sleep Deprivation

    30% reduction in habitual time in bed

    Other: Partial Sleep Deprivation

Interventions

  • OtherPartial Sleep Deprivation

    30% reduction in habitual time in bed

    Also known as: Reduced Sleep

06

What researchers measure

Primary outcomes

  1. Arterial Stiffness

    Carotid-femoral pulse wave velocity measured via applanation tonometry

    Time frame: Following 3-days of Acute Sleep Deprivation (i.e., 30% reduction in total time in bed) as well as following 3-days of Normal Sleep (i.e., 100% habitual time in bed); performed in a randomized order

07

Results

Posted Jun 8, 2026

Participant flow

First Intervention (4 days)
Participant flow — First Intervention (4 days)
MilestoneActive Group: Normal Sleep, Then Acute Sleep DeprivationActive Group: Acute Sleep Deprivation, Then Normal SleepSedentary Group: Normal Sleep, Then Acute Sleep DeprivationSedentary Group: Acute Sleep Deprivation, Then Normal Sleep
Started6666
Completed6666
Not completed0000
Washout (7 days)
Participant flow — Washout (7 days)
MilestoneActive Group: Normal Sleep, Then Acute Sleep DeprivationActive Group: Acute Sleep Deprivation, Then Normal SleepSedentary Group: Normal Sleep, Then Acute Sleep DeprivationSedentary Group: Acute Sleep Deprivation, Then Normal Sleep
Started6666
Completed6666
Not completed0000
Second Intervention (4 days)
Participant flow — Second Intervention (4 days)
MilestoneActive Group: Normal Sleep, Then Acute Sleep DeprivationActive Group: Acute Sleep Deprivation, Then Normal SleepSedentary Group: Normal Sleep, Then Acute Sleep DeprivationSedentary Group: Acute Sleep Deprivation, Then Normal Sleep
Started6666
Completed6666
Not completed0000

Outcome measures

PrimaryArterial Stiffness

Carotid-femoral pulse wave velocity measured via applanation tonometry

Time frame:
Following 3-days of Acute Sleep Deprivation (i.e., 30% reduction in total time in bed) as well as following 3-days of Normal Sleep (i.e., 100% habitual time in bed); performed in a randomized order
Reported as:
Mean · meters per second
Arterial Stiffness
meters per secondActive Group: Normal SleepActive Group: Acute Sleep DeprivationSedentary Group: Normal SleepSedentary Group: Acute Sleep Deprivation
Arterial Stiffness5.7 ± 0.65.4 ± 0.65.5 ± 0.75.7 ± 0.5

Adverse events

Collected over from enrollment through study completion, an average of 1 month. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Active Group: Normal Sleep0/12 (0%)0/12 (0%)0/12 (0%)
Active Group: Acute Sleep Deprivation0/12 (0%)0/12 (0%)0/12 (0%)
Sedentary Group: Normal Sleep0/12 (0%)0/12 (0%)0/12 (0%)
Sedentary Group: Acute Sleep Deprivation0/12 (0%)0/12 (0%)0/12 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Active Group: Normal Sleep, Then Acute Sleep DeprivationActive Group: Acute Sleep Deprivation, Then Normal SleepSedentary Group: Normal Sleep, Then Acute Sleep DeprivationSedentary Group: Acute Sleep Deprivation, Then Normal SleepTotal
Mean23.4 ± 5.823.4 ± 5.822.2 ± 4.222.2 ± 4.222.8 ± 5.0
Sex: Female, Male
Sex: Female, Male(Participants)Active Group: Normal Sleep, Then Acute Sleep DeprivationActive Group: Acute Sleep Deprivation, Then Normal SleepSedentary Group: Normal Sleep, Then Acute Sleep DeprivationSedentary Group: Acute Sleep Deprivation, Then Normal SleepTotal
Female232310
Male434314
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Active Group: Normal Sleep, Then Acute Sleep DeprivationActive Group: Acute Sleep Deprivation, Then Normal SleepSedentary Group: Normal Sleep, Then Acute Sleep DeprivationSedentary Group: Acute Sleep Deprivation, Then Normal SleepTotal
American Indian or Alaska Native00000
Asian10001
Native Hawaiian or Other Pacific Islander00000
Black or African American10214
White464519
More than one race00000
Unknown or Not Reported00000
08

Study locations

1 site
  • Institute of Sports Sciences and Medicine
    Tallahassee, Florida 32301, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · May 13, 2025

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Undecided

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT06956963
Lead sponsor
Florida State University
Responsible party
Michael J. Ormsbee (Professor, Florida State University) — Principal investigator
First posted
May 4, 2025
Start date
Jul 21, 2025
Primary completion
Jan 31, 2026
Completion
Jan 31, 2026
Results posted
Jun 8, 2026
Last update
Jun 8, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion